These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
615 related articles for article (PubMed ID: 27129181)
21. Hypertrophied myocardium is vulnerable to ischemia/reperfusion injury and refractory to rapamycin-induced protection due to increased oxidative/nitrative stress. Ma LL; Li Y; Yin PP; Kong FJ; Guo JJ; Shi HT; Zhu JB; Zou YZ; Ge JB Clin Sci (Lond); 2018 Jan; 132(1):93-110. PubMed ID: 29175946 [TBL] [Abstract][Full Text] [Related]
22. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction. Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462 [TBL] [Abstract][Full Text] [Related]
23. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression. Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509 [TBL] [Abstract][Full Text] [Related]
24. DPP-4 inhibition has beneficial effects on the heart after myocardial infarction. Kubota A; Takano H; Wang H; Hasegawa H; Tadokoro H; Hirose M; Kobara Y; Yamada-Inagawa T; Komuro I; Kobayashi Y J Mol Cell Cardiol; 2016 Feb; 91():72-80. PubMed ID: 26739213 [TBL] [Abstract][Full Text] [Related]
25. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice. Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101 [TBL] [Abstract][Full Text] [Related]
27. Oxidative stress and left ventricular remodelling after myocardial infarction. Hori M; Nishida K Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340 [TBL] [Abstract][Full Text] [Related]
28. Protease-activated receptor 2-mediated protection of myocardial ischemia-reperfusion injury: role of transient receptor potential vanilloid receptors. Zhong B; Wang DH Am J Physiol Regul Integr Comp Physiol; 2009 Dec; 297(6):R1681-90. PubMed ID: 19812353 [TBL] [Abstract][Full Text] [Related]
29. Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction. Inthachai T; Lekawanvijit S; Kumfu S; Apaijai N; Pongkan W; Chattipakorn SC; Chattipakorn N Exp Physiol; 2015 Jun; 100(6):667-79. PubMed ID: 25823534 [TBL] [Abstract][Full Text] [Related]
30. Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus. Rosa CM; Gimenes R; Campos DH; Guirado GN; Gimenes C; Fernandes AA; Cicogna AC; Queiroz RM; Falcão-Pires I; Miranda-Silva D; Rodrigues P; Laurindo FR; Fernandes DC; Correa CR; Okoshi MP; Okoshi K Cardiovasc Diabetol; 2016 Sep; 15(1):126. PubMed ID: 27585437 [TBL] [Abstract][Full Text] [Related]
31. Cardioprotection provided by Echinatin against ischemia/reperfusion in isolated rat hearts. Tian XH; Liu CL; Jiang HL; Zhang Y; Han JC; Liu J; Chen M BMC Cardiovasc Disord; 2016 May; 16():119. PubMed ID: 27246834 [TBL] [Abstract][Full Text] [Related]
32. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Directly Enhances the Contractile Recovery of Mouse Hearts at a Concentration Equivalent to that Achieved with Standard Dosing in Humans. Batchu SN; Yerra VG; Liu Y; Advani SL; Klein T; Advani A Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32796688 [TBL] [Abstract][Full Text] [Related]
33. Preservation of Glucagon-Like Peptide-1 Level Attenuates Angiotensin II-Induced Tissue Fibrosis by Altering AT1/AT 2 Receptor Expression and Angiotensin-Converting Enzyme 2 Activity in Rat Heart. Zhang LH; Pang XF; Bai F; Wang NP; Shah AI; McKallip RJ; Li XW; Wang X; Zhao ZQ Cardiovasc Drugs Ther; 2015 Jun; 29(3):243-55. PubMed ID: 25994830 [TBL] [Abstract][Full Text] [Related]
34. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury. Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182 [TBL] [Abstract][Full Text] [Related]
35. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury. Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418 [TBL] [Abstract][Full Text] [Related]
36. Timing of adenosine 2A receptor stimulation relative to reperfusion has differential effects on infarct size and cardiac function as assessed in mice by MRI. Yang Z; Linden J; Berr SS; Kron IL; Beller GA; French BA Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2328-35. PubMed ID: 18849340 [TBL] [Abstract][Full Text] [Related]
37. Infusion of Melatonin Into the Paraventricular Nucleus Ameliorates Myocardial Ischemia-Reperfusion Injury by Regulating Oxidative Stress and Inflammatory Cytokines. Yang JB; Kang YM; Zhang C; Yu XJ; Chen WS J Cardiovasc Pharmacol; 2019 Oct; 74(4):336-347. PubMed ID: 31356536 [TBL] [Abstract][Full Text] [Related]
38. The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction. Withaar C; Meems LMG; Markousis-Mavrogenis G; Boogerd CJ; Silljé HHW; Schouten EM; Dokter MM; Voors AA; Westenbrink BD; Lam CSP; de Boer RA Cardiovasc Res; 2021 Jul; 117(9):2108-2124. PubMed ID: 32871009 [TBL] [Abstract][Full Text] [Related]
39. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult. Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403 [TBL] [Abstract][Full Text] [Related]
40. The glucagon-like peptide 1 analog liraglutide reduces TNF-α-induced oxidative stress and inflammation in endothelial cells. Shiraki A; Oyama J; Komoda H; Asaka M; Komatsu A; Sakuma M; Kodama K; Sakamoto Y; Kotooka N; Hirase T; Node K Atherosclerosis; 2012 Apr; 221(2):375-82. PubMed ID: 22284365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]